Neuroprotective mixture for mitigating the harmful effects of ischemic stroke
AssigneeTricerapro Holding, LLC
InventorsJoseph L. Clark, Todd J. Crocco, Charles L. Rosen, Steven Cutright
Life of this patent
Estimating the term…
Abstract
A neuroprotective mixture includes Phosphocreatine (PCr), Magnesium Gluconate (MgG), and β-hydroxybutyrate (BHB). The PCR, MgG, and BHB are combined in a 2:1:2 molar ratio of PCr:MgH:BHB. The neuroprotective mixture is a useful preventative and prophylactic supplement, which also can function to extend the post-stroke treatment window.
Claims1
A method of mitigating the harmful effects of ischemic stroke in a person, comprising administering to that person a dietary supplement comprising a mixture of phosphocreatine, magnesium gluconate, and beta hydroxybutyrate in a 2:1:2 ratio, wherein the supplement is administered orally on a daily basis prior to the occurrence of a stroke to mitigate the harmful effects on the person of having a stroke.
Dependencies are inferred from the claim text.